WHITE HOUSE SURGERY
1 FAIRFAX RISE, SHEFFIELD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 6 | 9 | 66.7% | |
| HF 4 | 2011 | 6 | 8 | 75.0% | |
| HF 4 | 2012 | 12 | 13 | 92.3% | |
| HF 4 | 2013 | 16 | 18 | 88.9% | |
| HF004 | 2014 | 6 | 6 | 100.0% | |
| HF004 | 2015 | 5 | 7 | 71.4% | |
| HF004 | 2016 | 5 | 5 | 100.0% | |
| HF004 | 2017 | 15 | 19 | 78.9% | |
| HF004 | 2018 | 27 | 29 | 93.1% | |
| HF004 | 2019 | 31 | 32 | 96.9% | |
| HF004 | 2020 | 28 | 31 | 90.3% | |
| HF006 | 2021 | 36 | 40 | 90.0% | |
| HF006 | 2022 | 41 | 45 | 91.1% | |
| HF006 | 2023 | 45 | 47 | 95.7% |
